Health Catalyst, Inc.
HCAT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $1 | $1 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $1 | $2 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 3.6% | 7.1% | 14.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 45.9% | 44.5% | 48.2% | 48.6% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -3.5% | -23.1% | -30% | -42% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -22.7% | -39.9% | -49.7% | -63.3% |
| EPS Diluted | -1.15 | -2.09 | -2.54 | -3.23 |
| % Growth | 45% | 17.7% | 21.4% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |